ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer
Drug Delivery
◽
10.1080/10717544.2019.1693707
◽
2019
◽
Vol 26
(1)
◽
pp. 1265-1279
◽
Cited By ~ 7
Author(s):
Bingjie Wang
◽
Wei Zhang
◽
Xiudi Zhou
◽
Mengna Liu
◽
Xiaoya Hou
◽
...
Keyword(s):
Lung Cancer
◽
Hyaluronic Acid
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Tumor Associated Macrophages
Download Full-text
Related Documents
Cited By
References
Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.
Case Medical Research
◽
10.31525/ct1-nct03992885
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Clinical Study
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Egfr Mutations
◽
Small Cell Lung
Download Full-text
A Phase 1/2 Study Evaluating Multiple Nivolumab Combination Therapy in Participants With Stage IV Non-small Cell Lung Cancer That Has Spread or Has Reoccurred After Failure of Chemotherapy and Immunotherapy
Case Medical Research
◽
10.31525/ct1-nct04151563
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Tumor‐associated macrophages ( TAMs )‐derived osteopontin ( OPN ) upregulates PD‐L1 expression and predicts poor prognosis in non‐small cell lung cancer ( NSCLC )
Thoracic Cancer
◽
10.1111/1759-7714.14108
◽
2021
◽
Author(s):
Yue Li
◽
Hailin Liu
◽
Yujie Zhao
◽
Dongsheng Yue
◽
Chen Chen
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Poor Prognosis
◽
Small Cell
◽
Small Cell Lung
◽
Tumor Associated Macrophages
Download Full-text
Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non–Small-cell Lung Cancer: A Mini-review
Clinical Lung Cancer
◽
10.1016/j.cllc.2017.06.015
◽
2018
◽
Vol 19
(1)
◽
pp. 12-16
◽
Cited By ~ 31
Author(s):
Shinkichi Takamori
◽
Gouji Toyokawa
◽
Kazuki Takada
◽
Fumihiro Shoji
◽
Tatsuro Okamoto
◽
...
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Unconvincing Benefit of Combination Therapy With Gefitinib and Pemetrexed in Advanced Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
◽
10.1200/jco.2016.70.4148
◽
2017
◽
Vol 35
(6)
◽
pp. 691-692
◽
Cited By ~ 1
Author(s):
Akiko Ota
◽
Bishal Gyawali
◽
Ayumu Matsuoka
◽
Yuichi Ando
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Abstract 2933: Assessment of ABT-263 activity across a comprehensive cancer cell line collection leads to a novel, potent combination therapy for small cell lung cancer
10.1158/1538-7445.am2014-2933
◽
2014
◽
Cited By ~ 1
Author(s):
Anthony C. Faber
◽
Carlotta Costa
◽
Anahita Dastur
◽
Cyril Benes
◽
Jeffrey Engelman
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Line
◽
Cancer Cell
◽
Cell Lung Cancer
◽
Cancer Cell Line
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Abstract 2593: Combination therapy with EGFR-TKI and cMET-TKIs in non-small cell lung cancer: the golden duo
10.1158/1538-7445.am2015-2593
◽
2015
◽
Author(s):
Nele Van Der Steen
◽
Vanessa Deschoolmeester
◽
An Wouters
◽
Filip Lardon
◽
Christian Rolfo
◽
...
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Egfr Tki
Download Full-text
Abstract 2039: The use of self nano-emulsifying drug delivery systems to improve bioavailability of combination therapy and overcome erlotinib resistance in non-small cell lung cancer
10.1158/1538-7445.am2017-2039
◽
2017
◽
Author(s):
Ebony Nottingham
◽
Vasanth Sekar
◽
Arindam Mondal
◽
Mandip Sachdeva
Keyword(s):
Lung Cancer
◽
Drug Delivery
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Drug Delivery Systems
◽
Delivery Systems
◽
Small Cell
◽
Use Of Self
◽
Small Cell Lung
Download Full-text
Abstract CT227: KEYNOTE-495/KeyImPaCT: Phase II biomarker-directed precision oncology study of pembrolizumab-based combination therapy for non-small cell lung cancer
10.1158/1538-7445.sabcs18-ct227
◽
2019
◽
Author(s):
Martin Gutierrez
◽
Matthew D. Hellmann
◽
Matthew Gubens
◽
Charu Aggarwal
◽
Daniel Shao Weng Tan
◽
...
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Precision Oncology
◽
Small Cell Lung
Download Full-text
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report
BMC Cancer
◽
10.1186/s12885-020-6626-9
◽
2020
◽
Vol 20
(1)
◽
Cited By ~ 2
Author(s):
Yuta Adachi
◽
Naohiro Yanagimura
◽
Chiaki Suzuki
◽
Sakiko Ootani
◽
Azusa Tanimoto
◽
...
Keyword(s):
Lung Cancer
◽
Case Report
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Braf V600e
◽
Tumor Shrinkage
◽
Small Cell Lung
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close